Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$261,821
-$54,556 QoQ
Shares Held
10,873
-3.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#2,234
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Mar 31, 2021CallValue
$326,070
CallShares
9,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Lavaca Capital LLC holds $11,294,866 across 14 Drug Manufacturers - General names. PFE ranks #6 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
65,773 | $8,451,830 | |
| 2 | ABBV |
AbbVie Inc.
|
2,819 | $709,373 | |
| 3 | LLY |
ELI LILLY & Co
|
486 | $582,923 | |
| 4 | JNJ |
Johnson & Johnson
|
2,093 | $531,559 | |
| 5 | AZN |
Astrazeneca PLC
|
1,648 | $312,493 | |
| 6 | PFE |
Pfizer Inc
This page
|
10,873 | $261,821 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,489 | $188,120 | |
| 8 | BIIB |
Biogen Inc.
|
447 | $96,578 |
All Filings in PFE
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $261,821 | 10,873 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $316,377 | 11,267 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $264,637 | 10,628 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $238,518 | 9,361 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $226,425 | 9,341 | Shares | Sole | 2025-08-28 | |
| 2025-03-31 | $236,193 | 9,321 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $252,114 | 9,503 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $346,701 | 11,980 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $323,560 | 11,564 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $312,132 | 11,248 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $306,527 | 10,647 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $460,631 | 13,887 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $535,417 | 14,597 | Shares | Sole | 2023-08-28 | |
| 2023-03-31 | $1,062,758 | 26,048 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,322,350 | 25,807 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $665,239 | 15,202 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $796,621 | 15,194 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $786,179 | 15,186 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,144,164 | 36,311 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,858,505 | 43,211 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,781,231 | 45,486 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,444,438 | 67,470 | Shares | Sole | 2021-05-14 | |
| 2021-03-31 | $326,070 | 9,000 | Call | Sole | 2021-05-14 | |
| 2020-12-31 | $2,027,936 | 55,092 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $1,391,185 | 37,907 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $1,055,491 | 32,278 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $897,402 | 27,494 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||